News
NEWS
-
financingCelaid Therapeutics, developer of novel cell therapies, announces 500 million yen Series A financing.
-
newsCelaid will be speaking at the "ACADEMIA ENTREPRENEUR SUMMIT" hosted by Forbes
-
newsCelaid will participate in the semi-finals of the "Japan Healthcare Business Contest (JHeC)" organized by METI.
-
newsSelected to participate in JETRO's Acceleration program "SCAP"
-
newsCelaid will exhibit at "BioJapan 2022"
-
newsCelaid will participate in Nagoya City's pitch event "NAGOYA CONNÉCT".
-
newsCelaid will exhibit at Startup Discovery EXPO vol.2
-
newsCelaid's pitch video is now available on the JETRO channel.
-
newsCelaid Therapeutics will be a finalist in the "Boehringer Ingelheim Innovation Prize"!